XOOMAR

INTEGRATED BIOPHARMA INC (INBP)

Every FINRA and SEC series the site collects for INTEGRATED BIOPHARMA INC: short interest with days to cover, daily short sale volume, fails to deliver and Form 4 insider trades. Listed on OTC.

Download CSV

4

Short interest

settlement 2026-08-31

1.0

Days to cover

+100.0% vs prior

41,445

Fails to deliver

settlement 2025-06-09

Tue 22 Sep

Next earnings

estimated; last year 2025-09-23

$0

Insider flow, 90 days

0 buys, 0 sells

As of 2026-08-31.

Short interest

FINRA, twice a month; the last 12 months shown, all 48 settlements in the JSON

As of 31 August 2026, short interest in INBP is 4 shares, down 1,797 shares over the last month. Over the last 48 readings it ranged from 4 shares (31 August 2026) to 32,383 shares (31 December 2025). The latest reading sits at the bottom of that range. At the reported average volume of 13K shares a day that is 1.0 days to cover.

Embed this chartkeeps the attribution line it carries
<iframe src="https://xoomar.com/embed/stocks/inbp" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
PreviewDark previewAdd ?theme=dark to the src for a dark chart.
SettlementShares shortChangeAvg daily volumeDays to cover
2026-08-314+100.0%12,6171.00
2026-07-151,601-11.1%4,3941.00
2026-06-301,801+0.0%13,2741.00
2026-06-151,801-14.3%6,0661.00
2026-05-292,101+0.0%22,3071.00
2026-05-152,101+0.0%14,9291.00
2026-04-302,101+0.0%27,4811.00
2026-04-152,101+0.0%8,1001.00
2026-03-312,101-73.2%13,2211.00
2026-03-137,849+5.2%1,3895.65
2026-02-277,458+255.0%14,9861.00
2026-02-132,101-22.2%30,6101.00
2026-01-302,702-78.3%24,6031.00
2026-01-1512,440-61.6%24,3341.00
2025-12-3132,383+126.5%74,6751.00
2025-12-1514,300+376.7%43,2541.00
2025-11-283,000+100.0%55,6011.00
2025-10-154,700-31.1%17,0171.00
2025-09-306,819+354.6%26,8901.00
2025-09-151,500+100.0%18,8871.00
2025-05-308,431+100.0%36,0001.00
2025-04-157,220+359.3%21,2731.00
2025-03-311,572-67.3%25,3731.00
2025-03-144,805+1369.4%16,8941.00

Fails to deliver

SEC, by settlement date. JSON

As of 9 June 2025, the fails-to-deliver balance in INBP is 41,445 shares, up 35,847 shares over the last settlement date. Over the last 52 readings it ranged from 1 share (8 September 2023) to 41,445 shares (9 June 2025). The latest reading sits at the top of that range.

SettlementShares failedPriceValue
2025-06-0941,445$0.30$12K
2025-06-065,598$0.26$1K
2025-06-042,497$0.28$699
2025-04-143,923$0.30$1K
2025-03-21360$0.30$108
2025-03-07375$0.30$113
2024-10-159,982$0.25$2K
2024-06-139$0.22$2
2023-12-147$0.25$2
2023-10-068,600$0.28$2K
2023-10-058,600$0.28$2K
2023-10-048,576$0.28$2K
2023-10-038,576$0.28$2K
2023-10-029,608$0.28$3K
2023-09-081$0.33$0
2022-09-011,463$0.54$790
2022-08-22863$0.54$466
2022-08-19763$0.54$412
2022-08-18763$0.48$366
2022-08-05473$0.52$246
2022-08-04473$0.50$237
2022-08-03473$0.49$232
2022-07-265,673$0.48$3K
2022-07-25673$0.50$337
2022-07-2122$0.56$12
2022-05-18826$0.80$661
2022-05-17826$0.79$653
2022-05-165,826$0.80$5K
2022-04-051,727$0.83$1K
2022-03-072,569$0.93$2K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for INBP in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Milmoe William H. (Director) on 2026-04-15.

DateInsiderTitleTypeSharesPriceValueOwned after
2026-04-15Milmoe William H.DirectorGift2.2M$0.00$0139K
2026-04-15Milmoe William H.DirectorGift9.0M$0.00$02.4M
2026-04-15Milmoe William H.n/aGift2.2M$0.00$0139K
2026-04-15Milmoe William H.n/aGift9.0M$0.00$02.4M
2026-04-15DeSantis Damonn/aGift2.2M$0.00$012.7M
2026-04-15DeSantis Damonn/aGift9.0M$0.00$010.5M
2026-04-15DESANTIS CARLn/aGift2.2M$0.00$00
2026-04-15DESANTIS CARLn/aGift9.0M$0.00$02.2M
2026-03-24Milmoe William H.n/aGift7K$0.00$011.5M
2026-03-24Milmoe William H.n/aGift1.4M$0.00$011.5M
2026-03-24DeSantis Damonn/aGift7K$0.00$01.4M
2026-03-24DeSantis Damonn/aGift1.4M$0.00$01.4M
2026-03-24DESANTIS CARLn/aGift7K$0.00$011.4M
2026-03-24DESANTIS CARLn/aGift1.4M$0.00$011.4M
2025-05-30Milmoe William H.Director,TenPercentOwnerGrant50K$0.09$5K139K
2025-05-21Canarick RobertDirectorGrant175K$0.09$16K234K
2025-05-21Masi DinaChief Financial OfficerGrant135K$0.09$12K347K
2025-05-21KAY CHRISTINACo-Chief Executive OfficerGrant144K$0.09$13K1.5M
2025-05-21RIVA SHEPPARDCo-Chief Executive OfficerGrant144K$0.09$13K1.5M
2024-11-25Masi DinaChief Financial OfficerGrant65K$0.09$6K212K
2024-11-25KAY CHRISTINACo-Chief Executive OfficerGrant56K$0.09$5K1.3M
2024-11-25RIVA SHEPPARDCo-Chief Executive OfficerGrant56K$0.09$5K1.3M
2023-09-20Masi DinaChief Financial OfficerGrant50K$0.09$5K147K
2023-09-20KAY CHRISTINACo-Chief Executive OfficerGrant50K$0.09$5K1.3M
2023-09-20RIVA SHEPPARDCo-Chief Executive OfficerGrant50K$0.09$5K1.3M
2023-05-30KAY CHRISTINACo-Chief Executive OfficerGift50K$0.34$17K1.8M
2023-05-30RIVA SHEPPARDCo-Chief Executive OfficerGift50K$0.34$17K1.8M
2023-05-25KAY CHRISTINACo-Chief Executive OfficerGrant3.4M$0.40$1.4M3.4M
2023-05-25RIVA SHEPPARDCo-Chief Executive OfficerGrant3.4M$0.40$1.4M3.4M
2022-05-06KAY E GERALDExecutive Chairman & PresidentGrant100K$0.23$23K5.3M
2022-05-06KAY E GERALDExecutive Chairman & PresidentOption exercise100K$0.23$23K5.3M

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are the rarer, stronger signal.

Large holders (13D and 13G)

One row per reporting person, newest filing first. JSON

5 holders above 5% have filed on INBP, 5 on Schedule 13D (active intent). The largest reported stake is DeSantis Damon at 41.3% of the class (12,920,558 shares), filed 2026-04-17 for an event on 2026-04-15.

FiledFormHolderSharesOf classEvent
2026-04-1713DDeSantis Damonindividual12.9M41.3%2026-04-15
2026-04-1713DCDDS 2.0, LLCother entity12.7M41.0%2026-04-15
2026-04-1713D/Ano. 4DESANTIS CARLindividual00.0%2026-04-15
2026-04-1713D/Ano. 4CD Financial, LLCother entity00.0%2026-04-15
2026-04-1713D/Ano. 4CDS Group Holdings, L.L.C.other entity00.0%2026-04-15

What this page is

INTEGRATED BIOPHARMA INC in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page pulls every series the site collects for one ticker onto one URL, keyed by the SEC's own ticker list, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a summary sentence built from the rows (last value, change, range with dates) and its own JSON and CSV links. Nothing on the page is written by a model; the sentences change only when the data does. A page exists only for companies with data in at least two series, and every section says when its source last updated.

This page follows INTEGRATED BIOPHARMA INC (INBP), SEC CIK 1016504, listed on OTC. The cross-market tables live on the short interest and insider transactions hubs.

Source and method

Short interest
FINRA consolidated short interestTwice a month, about eight business days after settlement. Latest 2026-08-31.JSON and CSV
Fails to deliver
SEC fails-to-deliver dataTwice a month, a few weeks after the half month ends. Latest 2025-06-09.JSON and CSV
Large holders
SEC EDGAR Schedule 13D and 13GEDGAR read every 30 minutes; 13D within five business days of crossing 5%, 13G on the passive schedule. Latest 2026-04-17.JSON and CSV
Earnings dates
SEC EDGAR 8-K Item 2.02 (full-text search)EDGAR full-text search read twice a day; the estimate is last year's date plus 52 weeks. Latest 2026-05-08.JSON and CSV
Insider trades
SEC EDGAR Form 4EDGAR read every 30 minutes; filings are due two business days after the trade. Latest 2026-04-15.JSON and CSV
Company record
EDGAR filing index for CIK 1016504Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits
30 requests a minute without a key, 120 a minute with a key from a free account.

Data checks. Every dataset is checked against its source once a day. This dataset passed the last run, 18 Sep 05:40 UTC.

How to read it

  • Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
  • Insider buys next to a crowded short are the combination that has historically preceded squeezes; insider sells next to a crowded short are common and mean little.
  • Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Other company pages

Datasets

Frequently Asked Questions

How much of INBP is sold short?
4 shares were held short at the 2026-08-31 settlement, 1.0 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is INBP's daily short volume?
No daily short volume file lists INBP yet.
Does INBP have fails to deliver?
The SEC's latest file shows 41,445 INBP shares failed to deliver at settlement 2025-06-09. Fails are reported per settlement date and published twice a month with a lag.
Are INBP insiders buying or selling?
No open-market insider trades were reported for INBP in the last 90 days. The most recent filings are listed below; grants and option exercises carry a weaker signal than voluntary trades. Latest filing: Milmoe William H. (Director) on 2026-04-15.
Who owns more than 5% of INBP?
5 holders above 5% have filed on INBP, 5 on Schedule 13D (active intent). The largest reported stake is DeSantis Damon at 41.3% of the class (12,920,558 shares), filed 2026-04-17 for an event on 2026-04-15.

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.